Immunization has been one of the greatest success stories in the history of U.S. and global public health. The widespread use of vaccines have prevented millions of deaths from smallpox, polio, diphtheria, measles, pertussis, and tetanus.
Abt Associates ensures that this progress continues in the U.S. We also extend the full benefits of immunization to children in developing nations.
Our immunization-related work has included:
Flu vaccine effectiveness – Abt currently runs three large vaccine effectiveness studies for the Centers for Disease Control and Prevention (CDC). These studies, while originally focusing on H1N1, are now designed to evaluate the current flu vaccine, which is meant to prevent both seasonal flu as well as H1N1.
Vaccine attitudes – There is controversy about vaccination in the U.S., and many high-risk populations are reluctant to get vaccinated. This reluctance is not limited to flu vaccine but is also common in childhood vaccination decision making. Abt Associates and Abt SRBI are conducting a flu vaccine survey for pregnant women twice a year for CDC.
Study of thimerosal related to autism – An Abt study added to the evidence that prenatal and early-life exposure to ethylmercury from thimerosal in vaccines or immunoglobulin products does not increase a child's risk of developing autism.